![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: John Wiley & Sons Inc
E-ISSN: 1399-3038|29|1|90-93
ISSN: 0905-6157
Source: PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol.29, Iss.1, 2018-02, pp. : 90-93
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Omalizumab for Severe Allergic Asthma: 7 Years and Open Questions
Respiration, Vol. 88, Iss. 2, 2014-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Serum Chitotriosidase Levels in Patients with Allergic and Non-Allergic Asthma
Respiration, Vol. 79, Iss. 5, 2010-01 ,pp. :